NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101

BACKGROUND: In this exploratory analysis of EORTC 26101, a randomized phase III clinical study comparing single-agent lomustine with lomustine plus bevacizumab in patients with progressive glioblastoma, development of necrosis on treatment was radiographically assessed and compared to outcome. METHO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Nowosielski, Martha, Gorlia, Thierry, Bromberg, Jacolien, Sahm, Felix, Harting, Inga, Kickingereder, Philipp, Brandes, Alba, Taphoorn, Martin J B, Taal, Walter, Domont, Julien, Idbaih, Ahmed, Campone, Mario, Clement, Paul, Weller, Michael, Fabbro, Michel, Dubois, Francois, Platten, Michael, Golfinopoulos, Vassilis, Bendszus, Martin, van den Bent, Martin, Wick, Wolfgang
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692885/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.647
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars